Arnold Milstein MD Arnold Milstein MD Paul Schimmel PhD Alan Ezekowitz    

Jonathan Bush

Arnold Milstein

Paul Schimmel

Alan Ezekowitz

Charles G. Hadley

Chuck Hadley began his venture capital career with Hillman Medical Ventures, an early stage medical technology fund, which he co-founded in 1988. He led that firm's medical device sector investing. He was the founding investor in Ultracision (acquired by Johnson & Johnson) and led the firm's investments in several other device and diagnostics companies, including Cytyc (NQ:CYTC later merged with Hologic NQ:HOLX), Dynamic Digital Displays (acquired by Picker International), Fiberoptic Sensor Technologies (acquired by C.R. Bard) and Endius (acquired by Zimmer).

In 1997, Chuck founded Rock Hill Ventures. There he founded several medical technology companies, including Talaria Therapeutics (acquired by Esperion Therapeutics, later acquired by Pfizer) and Replication Medical. He also managed the Hillman Company's investment in Proxima Therapeutics. Hillman was the largest investor in Proxima which was acquired by Cytyc. Chuck is currently chairman of the board of Bioconnect Systems, Fluidnet and Replication Medical.

Chuck is a Phi Beta Kappa graduate of the George Washington University and received his J.D. and M.B.A. degrees from Stanford University in 1983.